“Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy With Baricitinib 4-Mg: Results From BRAVE-AA1 and -AA2 Trials”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s522. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/3165.